HIGHLIGHTS
- who: Ze Zhang from the Department of Interventional Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China have published the research work: Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma, in the Journal: (JOURNAL) of September/22,/2020
- what: The study investigated the efficacy and safety of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma. The study shows that patients with unresectable recurrent HCC after radical surgery who have not previously received systemic therapy can also achieve . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.